| NCT Number | NCT06926062 |
| Lead Sponsor | Fred Hutchinson Cancer Center
Collaborators: Merck Sharp & Dohme LLC |
| Conditions | Human Papillomavirus-Related Carcinoma |
| Enrollment | 1,900 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2027-08-01 (estimated) |
| Study Completion | 2027-12-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-30 |